How ACTH Causes Hyperpigmentation
ACTH causes hyperpigmentation because it shares a common precursor molecule (proopiomelanocortin) with melanocyte-stimulating hormone (MSH), and elevated ACTH levels directly stimulate melanocytes to produce melanin through the melanocortin 1 receptor (MC1R). 1
Molecular Mechanism
The pigmentation occurs through a well-defined biochemical pathway:
ACTH and α-MSH are both derived from the same prohormone called proopiomelanocortin (POMC), which explains why elevated ACTH has melanogenic properties 1
ACTH directly binds to MC1R on melanocytes, stimulating tyrosinase activity—the rate-limiting enzyme in melanin production 2
At physiological plasma concentrations (10⁻⁸ to 10⁻⁷ mol/L), ACTH produces a 50% increase in melanin content of melanocytes 2
The dose-response curve for ACTH is biphasic, differing from the sigmoidal curves of MSH peptides, suggesting ACTH may be relatively more important than α-MSH as a pigmentary hormone in humans 2
Clinical Context in Primary Adrenal Insufficiency
In primary adrenal insufficiency (Addison's disease), the mechanism is straightforward:
Cortisol deficiency leads to loss of negative feedback on the hypothalamic-pituitary axis 3
This results in compensatory elevation of plasma ACTH (typically >2-fold above the upper limit of normal, often >66 pmol/L) 3
The chronically elevated ACTH continuously stimulates melanocytes, producing the characteristic hyperpigmentation 3
Distribution Pattern
Hyperpigmentation in primary adrenal insufficiency appears characteristically in:
- Sun-exposed areas
- Skin creases
- Mucosal membranes
- Scars
- Areola of breast 3
This distribution reflects areas where melanocytes are more concentrated or more responsive to ACTH stimulation.
Clinical Significance
Hyperpigmentation is a key diagnostic feature that distinguishes primary from secondary adrenal insufficiency, as secondary AI (due to pituitary ACTH deficiency) does not cause pigmentation 3. The presence of hyperpigmentation in an acutely ill patient with unexplained hypotension, hyponatremia, and hyperkalemia should prompt immediate consideration of primary adrenal insufficiency 3.
Reversibility
The pigmentation is reversible with adequate glucocorticoid replacement that suppresses ACTH levels. Recent evidence shows that low-dose dexamethasone (0.5 mg/day) added to standard replacement therapy can normalize ACTH levels and regress hyperpigmentation without causing Cushingoid features 4. Standard hydrocortisone replacement alone may not fully suppress ACTH enough to reverse established pigmentation 4.